A $4.4 million grant from the Department of Defense will help researchers test two drug candidates for idiopathic pulmonary fibrosis — a deadly disease with no cure. Continue reading
Category Archives: AZBio News
$2.5M Grant to UA Nursing Professor to Ease Cancer Patients’ and Caregivers’ Psychological Distress
The four-year National Cancer Institute grant will enable Terry A. Badger, PhD, to study a precision approach to decreasing psychological distress in both cancer patients and their family caregivers during treatment.Continue reading
bioSyntagma Wins AZBio Fast Lane Award
The Arizona Bioindustry Association (AZBio) today announced that BioSyntagma has won a 2018 AZBio Fast Lane Award in recognition of its rapid progression in product development and its proven ability to generate both government grants and operational revenues to move the company forward. The bioSyntagma team will be honored by Arizona’s bioscience and business communities at the 2018 AZBio Awards on October 3, 2018 at the Phoenix Convention Center.Continue reading
UA College of Pharmacy Appoints Dr. Wei Wang Director of Drug Discovery Program
Internationally noted chemist joins the UA Department of Pharmacology and Toxicology as a professor in this newly created position.
Dr. Wang joins as the college begins construction on the Skaggs Pharmaceutical Sciences Center Sept. 4.Continue reading
Researchers Test Autobiographical Memory for Early Alzheimer’s Detection
UA psychologist Matthew Grilli found that people who carry a gene variant that increases the risk for Alzheimer’s disease have greater difficulty describing detailed memories of past events.Continue reading
AdviNow Medical Wins AZBio Fast Lane Award
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that AdviNow Medical has won a 2018 AZBio Fast Lane Award for its rapid progression from concept to exciting product launch. The AdviNow Medical team will be honored by Arizona’s bioscience and business communities at the 2018 AZBio Awards on October 3, 2018 at the Phoenix Convention Center.Continue reading
Mayo neurologist and ASU professor hope to identify a blood-based biomarker to diagnose early-stage Parkinson’s disease
In 1999, when Americans watched as Michael J. Fox — beloved to many as the smooth, wisecracking Marty McFly — swayed and shifted uncontrollably, clenching and unclenching his fists as he provided solemn testimony to the U.S. Senate Appropriations Subcommittee on the realities of life with Parkinson’s, it drew attention to a disease that affects nearly 1 million people in the U.S. and nearly 5 million worldwide.Continue reading